Loading...

Conan Macdougall, PharmD

TitleProfessor
SchoolUCSF School of Pharmacy
DepartmentClinical Pharmacy
Address513 Parnassus Ave, Med Sci
San Francisco CA 94122
Phone415-502-9573
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoTeaching Scholars Certificate2013School of Medicine
    University of California, San FranciscoM.A.S. in Clinical Research2008 School of Medicine
    Virginia Commonwealth UniversityInfectious Diseases Fellowship2005School of Pharmacy
    University of California, San Francisco PGY-2 Residency, Infectious Diseases2004School of Pharmacy
    Duke University Medical CenterPGY-1 Residency2003
    University of California, San FranciscoPharm.D.2002 Pharmacy
    Collapse Awards and Honors
    UCSF School of Pharmacy2011  - 2012Long Prize for Excellence in Teaching
    UCSF2009Academic Senate Award for Distinction in Teaching
    UCSF School of Pharmacy2007  - 2008Long Prize for Excellence in Teaching
    Pharmacy Leadership & Education Institute2012Albert B. Prescott Pharmacy Leadership Award

    Collapse Overview 
    Collapse Overview
    Conan MacDougall, PharmD, MAS, BCPS is an Associate Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California, San Francisco. He provides clinical service to the Infectious Diseases Consult Service at UCSF Medical Center and is co-director of UCSF's antimicrobial management program. His clinical research interests include the pharmacoepidemiology of antimicrobial use in hospitals and communities and associations between antimicrobial use and resistance.

    Dr. MacDougall is involved in education at multiple levels at UCSF, serving as co-coordinator of the clinical pharmacy therapeutics course in infectious diseases and oncology, precepting students on the infectious diseases rotation, directing the pharmacy specialty residency in infectious diseases, serving as a member of the school's Educational Policy Committee, and serving on UCSF's Committee on Courses of Instruction. His educational interests include development of integrated curricula, incorporation of active learning in the classroom, use of branched-logic case simulations, and student preparation for interprofessional education.


    Collapse ORNG Applications 
    Collapse Websites
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. MacDougall C, Schwartz BS, Kim L, Nanamori M, Shekarchian S, Chin-Hong PV. An Interprofessional Curriculum on Antimicrobial Stewardship Improves Knowledge and Attitudes Toward Appropriate Antimicrobial Use and Collaboration. Open Forum Infect Dis. 2017; 4(1):ofw225. PMID: 28480231.
      View in: PubMed
    2. Narayanan N, Johnson L, MacDougall C. Beyond Susceptible and Resistant, Part III: Treatment of Infections due to Gram-Negative Organisms Producing Carbapenemases. J Pediatr Pharmacol Ther. 2016 Mar-Apr; 21(2):110-9. PMID: 27199618; PMCID: PMC4869768.
    3. Narayanan N, Gross AK, Pintens M, Fee C, MacDougall C. Effect of an electronic medical record alert for severe sepsis among ED patients. Am J Emerg Med. 2016 Feb; 34(2):185-8. PMID: 26573784.
      View in: PubMed
    4. Justo JA, Gauthier TP, Scheetz MH, Chahine EB, Bookstaver PB, Gallagher JC, Hermsen ED, DePestel DD, Ernst EJ, Jacobs DM, Esterly JS, Suda KJ, Olsen KM, Abbo LM, MacDougall C. Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials. Clin Infect Dis. 2014 Oct 15; 59 Suppl 3:S162-9. PMID: 25261543; PMCID: PMC4303059.
    5. Curello J, MacDougall C. Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum ß-Lactamases. J Pediatr Pharmacol Ther. 2014 Jul; 19(3):156-64. PMID: 25309145; PMCID: PMC4187532.
    6. MacDougall C. The nonpharmacologic basis of therapeutics: to get to the next level in interprofessional patient care, pharmacists need to recognize the social and interpersonal aspects of medical decision making. J Am Pharm Assoc (2003). 2012 Jul-Aug; 52(4):454-6. PMID: 22825222.
      View in: PubMed
    7. Ferrara JJ, MacDougall C, Gallagher JC. Empiric antifungal therapy in patients with febrile neutropenia. Pharmacotherapy. 2011 Apr; 31(4):369-85. PMID: 21449626.
      View in: PubMed
    8. Macdougall C. Beyond Susceptible and Resistant, Part I: Treatment of Infections Due to Gram-Negative Organisms With Inducible ß-Lactamases. J Pediatr Pharmacol Ther. 2011 Jan; 16(1):23-30. PMID: 22477821; PMCID: PMC3136230.
    9. Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. J Am Pharm Assoc (2003). 2010 Nov-Dec; 50(6):677-85. PMID: 21071311.
      View in: PubMed
    10. Kim-Katz SY, Anderson IB, Kearney TE, MacDougall C, Hudmon KS, Blanc PD. Topical antacid therapy for capsaicin-induced dermal pain: a poison center telephone-directed study. Am J Emerg Med. 2010 Jun; 28(5):596-602. PMID: 20579556.
      View in: PubMed
    11. Rafie S, MacDougall C, James CL. Cethromycin: a promising new ketolide antibiotic for respiratory infections. Pharmacotherapy. 2010 Mar; 30(3):290-303. PMID: 20180612.
      View in: PubMed
    12. Gallagher JC, Perez ME, Marino EA, LoCastro LG, Abrardo LA, MacDougall C. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients. Pharmacotherapy. 2009 Jul; 29(7):792-9. PMID: 19558253.
      View in: PubMed
    13. Drew RH, White R, MacDougall C, Hermsen ED, Owens RC. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy. 2009 May; 29(5):593-607. PMID: 19397466.
      View in: PubMed
    14. Pakyz AL, MacDougall C, Oinonen M, Polk RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med. 2008 Nov 10; 168(20):2254-60. PMID: 19001203.
      View in: PubMed
    15. MacDougall C, Polk RE. Variability in rates of use of antibacterials among 130 US hospitals and risk-adjustment models for interhospital comparison. Infect Control Hosp Epidemiol. 2008 Mar; 29(3):203-11. PMID: 18257689.
      View in: PubMed
    16. Loffler CA, Macdougall C. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections. Expert Rev Anti Infect Ther. 2007 Dec; 5(6):961-81. PMID: 18039081.
      View in: PubMed
    17. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. J Am Pharm Assoc (2003). 2007 Sep-Oct; 47(5):613-5. PMID: 17848351.
      View in: PubMed
    18. Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007 Mar 01; 44(5):664-70. PMID: 17278056.
      View in: PubMed
    19. Phillips S, MacDougall C, Holdford DA. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus. Ann Pharmacother. 2007 Jan; 41(1):13-20. PMID: 17200425.
      View in: PubMed
    20. Bryner JK, Wang UK, Hui JW, Bedodo M, MacDougall C, Anderson IB. Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004. Arch Pediatr Adolesc Med. 2006 Dec; 160(12):1217-22. PMID: 17146018; PMCID: PMC2257867.
    21. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005 Oct; 18(4):638-56. PMID: 16223951; PMCID: PMC1265911.
    22. MacDougall C, Harpe SE, Powell JP, Johnson CK, Edmond MB, Polk RE. Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use. Emerg Infect Dis. 2005 Aug; 11(8):1197-204. PMID: 16102307; PMCID: PMC3320507.
    23. MacDougall C, Powell JP, Johnson CK, Edmond MB, Polk RE. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005 Aug 15; 41(4):435-40. PMID: 16028149.
      View in: PubMed
    24. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis. 2005 Mar; 11(3):380-4. PMID: 15757551; PMCID: PMC3298265.
    25. MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. J Antimicrob Chemother. 2004 Jun; 53(6):899-901. PMID: 15140857.
      View in: PubMed
    26. Gallagher JC, MacDougall C, Ashley ES, Perfect JR. Recent advances in antifungal pharmacotherapy for invasive fungal infections. Expert Rev Anti Infect Ther. 2004 Apr; 2(2):253-68. PMID: 15482191.
      View in: PubMed
    Conan's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP